Immunosuppression in liver transplantation: Beyond calcineurin inhibitors
John Fung, Dympna Kelly, Zakiyah Kadry, Kusum Patel‐Tom, Bijan Eghtesad – 17 February 2005 – Although calcineurin inhibitors (CNIs) remain the mainstay of immunosuppression in liver transplantation (LTX), their long‐term toxicity significantly contributes to morbidity and mortality. The elucidation of mechanisms of alloimmunity and leukocyte migration have provided novel targets for immunosuppression development. The toxicities of these agents differ from that of the CNI and act additively or synergistically.